Holiday Notification: Cayman Chemical will be closed Monday, September 6, 2010, in observance of the Labor Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, September 7, 2010. Thank you for your patience.
Research Area · Obesity
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004303 |
11β- |
- | >98% |
|
2004-08-12 | 142.775093922652 | 11-hydroxysteroid-dehydrogenase-type-1-polyclonal-antibody | 11β-HSD1; Corticosteroid 11β-Dehydrogenase Isozyme 1 | antibodies western blots blotting 11.beta.-OH-steroid dehydrogenases steroids 11beta-OH-steroid 11b-hydroxysteroid antisera antiserum WB 11b-HSD 11beta-HSD 11.beta.-HSD 11b HSD endocrinology immunoblotting IHC immunohistochemistry | ||
| 10010132 |
15- |
- | ≥98% (isomer mixture) |
|
2008-06-09 | 41.442289748312 | 15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester | 15-deoxy-Δ12,14-PGJ2-2-glycerol ester | PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG | ||
| 10006908 | Adipogenesis Assay Kit | - |
|
2006-08-18 | 79.845113008538 | adipogenesis-assay-kit | obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines endocrinology cell-based assays cell based assay cba | ||||
| 10009381 | Adipolysis Assay Kit | - |
|
2007-07-30 | 41.588784530386 | adipolysis-assay-kit | obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines lipolysis 3T3L1 kits assays FFA adipocytes endocrinology cell-based assay cell based assay cba | ||||
| 500641 | Adiponectin (human) EIA Kit | - |
|
2006-03-22 | 76.955801104972 | adiponectin-human-eia-kit | GBP-28 (human) EIA Kit; AdipoQ (human) EIA Kit; Acpr30 (human) ELISA Kit | 10007618 calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neuroscience A05185 adipokines endocrinology assays | |||
| 10007619 | Adiponectin (human) EIA Kit (HS) | - |
|
2006-03-22 | 63.490331491712 | adiponectin-human-eia-kit-hs | GBP-28 (human) EIA Kit; AdipoQ (human) EIA Kit; Acpr30 (human) ELISA Kit | calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio adipokines neuroscience spi-bio spibio A05186 endocrinology assays | |||
| 10007620 | Adiponectin (murine) EIA Kit | - |
|
2006-07-11 | 105.776243093922 | adiponectin-murine-eia-kit | GBP-28 (murine) EIA Kit; AdipoQ (murine) EIA Kit; Acpr30 (murine) ELISA Kit | SPI-Bio spibio kits enzyme immunoassays A05187 adipokines endocrinology assays | |||
| 10338 | AdPLA2 Blocking Peptide New | - | 2010-03-11 | 29.507905327058 | adpla2-blocking-peptide | HRASLS3; Adipose Phospholipase A2; HRAS-like supressor 3 | HREV 107-3 PLA2GXVI | ||||
| 10337 | AdPLA2 Polyclonal Antibody New | - |
|
2010-03-10 | 109.007489257213 | adpla2-polyclonal-antibody | HRAS-Like Suppressor 3; Adipose Phospholipase A2 | western blots WB fatty acids phospholipase adipocyte tissues differentiation obesity HREV 107-3 PLA2GXVI immunoblotting blotting | |||
| 10010241 | AICAR | 2627-69-2 | >98% |
|
2008-02-25 | 245.893950276243 | aicar | NSC 105823; Acadesine; AICA Riboside | AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide | ||
| 13452 | AM3102 Exclusive | 213182-22-0 | ≥98% |
|
✓ | 2009-08-11 | 11.745552486188 | am3102 | KDS-5104 | OEA PPARs PPARα agonist KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity | |
| 13079 | ApoAI Blocking Peptide | - | 2008-09-30 | 9.689502762431 | apoai-blocking-peptide | Apolipoprotein A-I; Apolipoprotein AI | antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots | ||||
| 13042 | ApoAI Monoclonal Antibody (Clone CC3821C4) Exclusive | - | ✓ | 2008-10-15 | 17.531325966850 | apoai-monoclonal-antibody-clone-cc3821c4 | Apolipoprotein AI | antibodies HDL high-density lipoproteins WB western blots polypeptide immunoblotting blotting A-I A-1 apopipoproteins | |||
| 600140 | Autophagy/Cytotoxicity Dual Staining Kit | - |
|
2009-07-14 | 90.794762430939 | autophagy-cytotoxicity-dual-staining-kit | assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis | ||||
| 10009021 |
AVE- |
358970-97-5 | >98% |
|
✓ | 2008-04-03 | 9.255248618785 | ave-1625 | cannabinoids CB1 receptors schizophrenia parkinsons disease alzheimers disease metabolism obesity SR-141716 lipolysis glycogenolysis antagonist endocrinology neurochemistry | ||
| 10005270 | C75 | 191282-48-1 | >98% |
|
2004-09-22 | 29.944714548802 | c75 | inhibits inhibitors inhibition fatty acids synthases FAS cerulenin cytotoxicity apoptosis cancers anorexigenic stable weight loss feeding endocrinology | |||
| 10007875 | CAY10499 Exclusive | 359714-55-9 | >98% |
|
✓ | 2006-07-25 | 23.061418047882 | cay10499 | obesity lipases diabetes triglycerides diacylglycerol inhibitors steroidogenesis spermatogenesis atherosclerosis HSL hormone sensitive endocrinology | ||
| 10008669 | CAY10508 | 878533-35-8 | >98% |
|
2006-08-04 | 43.478629834253 | cay10508 | 1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 | |||
| 10012562 | CAY10566 | 944808-88-2 | ≥98% |
|
2009-01-07 | 11.287292817680 | cay10566 | SCD1 long chain fatty acids monounsaturated type 2 two diabetes dyslipidemia obesity | |||
| 13143 | CAY10587 Exclusive | 1082058-99-8 | ≥98% |
|
✓ | 2009-07-02 | 11.520883977900 | cay10587 | free fatty acid receptor1 FFA1 GPR40 pancreatic b-cells glucose insulin diabetes obesity metabolic syndrome receptors | ||
| 10009797 | CAY10591 Exclusive | 839699-72-8 | >98% |
|
✓ | 2008-04-21 | 21.326034849128 | cay10591 | Sirtuin 1 Activator 3; SIRT1 Activator 3 | p53 HDACs inhibits inhibitors inhibitions SIRTs sirtuins class III TNFalpha TNF.alpha. THP-1 cells anti-obesity anti-diabetic | |
| 10009796 | CAY10602 | 374922-43-7 | ≥95% |
|
2009-07-15 | 11.461740331491 | cay10602 | SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB | |||
| 10005647 | Cerulenin | 17397-89-6 | >98% |
|
2004-09-01 | 27.366878453038 | cerulenin | tumor cells fatty acid synthases FAS inhibits inhibitors inhibition cytotoxicity apoptosis cancer diet obesity | |||
| 10007171 | Cetaben | 55986-43-1 | >98% |
|
2005-11-11 | 8.904295580110 | cetaben | Hexadecylamino-p-amino Benzoic Acid | clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology | ||
| 10325 |
Chemokine- |
- |
|
2010-01-25 | 83.827059545733 | chemokine-like-receptor-1-polyclonal-antibody | ChemR23; CMKLR1; DEZ; ChemerinR; Resolvin E1 Receptor; GPCR ChemR23 | immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR | |||
| 10007640 | Cholesterol Assay Kit | - |
|
2006-02-28 | 109.417734806629 | cholesterol-assay-kit | Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis assays fluorescent fluorometric | ||||
| 10006790 | ChREBP Blocking Peptide | - | 2007-06-06 | 0E-12 | chrebp-blocking-peptide | WBSCR14; Carbohydrate Response Element-binding Protein | proteins diseases WB western blots blotting ICC immunocytochemistry transcription factors nutrients hormonal regulations genes encoding enzymes glucose metabolisms lipogenesis pathways domains nuclear localization signals NLS N-terminus polyprolines basic tissues livers kidneys adipose basal cytosols proteins nucleus dephosphorylations mouse fat HepG2 cells | ||||
| 10010060 |
ChREBP Cell- |
- |
|
2007-08-15 | 12.783215469613 | chrebp-cell-based-translocation-assay-kit | Carbohydrate Response Element-Binding Protein Cell-Based Translocation Assay Kit | assays kits transcription factors TFs diabetes nutrients hormones hormonal regulation genes encoding enzymes glucose metabolisms lipogenesis dephosphorylated cytoplasm protein Ser196 nucleus liver obesity tolerance drugs discovery modulators sub-cellular localization ICC immunocytochemical stains staining antibody antibodies DyLightTM Pierce Biotechnology Inc. fluorescence fluorescent fluorometric endocrinology cell-based assay cell based assay cba | |||
| 10009524 | ChREBP DBD (human recombinant) | - | >85% by SDS-PAGE | 2007-04-12 | 1.620372928176 | chrebp-dbd-human-recombinant | GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain | EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology | |||
| 10009753 | ChREBP DBD Western Ready Control | - | 2007-05-03 | 2.160497237569 | chrebp-dbd-western-ready-control | Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams Beuren Syndrome Chromosome Region 14 | WB western blot western blotting Thr666 PP2A carbohydrate response element CRE L-type pyruvate kinase L-PK glucose Ser196 endocrinology | ||||
| 10006909 | ChREBP Transcription Factor Assay Kit | - |
|
2006-07-12 | 41.637783149171 | chrebp-transcription-factor-assay-kit | Carbohydrate Response Element-Binding Protein | tf chrebps carbohydrate response element binding protein glucose liver insulin obesity adipokines endocrinology assays | |||
| 10005745 | Clofibrate | 637-07-0 | >98% |
|
2004-09-14 | 19.326398794575 | clofibrate | PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate | |||
| 500360 | Cortisol EIA Kit New | - |
|
2010-04-26 | 0E-12 | cortisol-eia-kit | 582121 kits assays EIAs ELISAs enzymes immunoassays glucocorticoids adrenal cortex adrenocorticotropic hormones ACTH circadian stress biomarker major depressive disorders hypertension AIDS cognitive impairment bone density type II 2 diabetes intracellular receptors mineralocorticoid receptors MRs glucocorticoid GRs 11β-hydroxysteroid dehydrogrenase 11β-HSD2 cortisone kidney colon salivary gland enzymes hypokalemia 11β-HSD1 visceral adipose tissues obese blood feces urine saliva proteins urinary glomerular tubular serums sample matrix matrices | ||||
| 500361 | Cortisol EIA Kit (Solid Plate) New | - |
|
2010-04-26 | 0E-12 | cortisol-eia-kit-solid-plate | 582121.1 kits assays EIAs ELISAs enzymes immunoassays glucocorticoids adrenal cortex adrenocorticotropic hormones ACTH circadian stress biomarker major depressive disorders hypertension AIDS cognitive impairment bone density type II 2 diabetes intracellular receptors mineralocorticoid receptors MRs glucocorticoid GRs 11β-hydroxysteroid dehydrogrenase 11β-HSD2 cortisone kidney colon salivary gland enzymes hypokalemia 11β-HSD1 visceral adipose tissues obese blood feces urine saliva proteins urinary glomerular tubular serums sample matrix matrices | ||||
| 500370 | Cortisol Express EIA Kit New | - |
|
2010-05-20 | 0E-12 | cortisol-express-eia-kit | Cortisol Express ELISA Kit | 10006791 EIAs steroids antisera hormones immunoassays reagents antiserums kits ELISAs enzymes glucocorticoids adrenal cortex adrenocorticotropic hormones ACTH circadian stress biomarker major depressive disorders hypertension AIDS cognitive impairment bone density type II 2 diabetes intracellular receptors mineralocorticoid receptors MRs glucocorticoid GRs 11β-hydroxysteroid dehydrogrenase 11β-HSD2 cortisone kidney colon salivary gland hypokalemia 11β-HSD1 visceral adipose tissues obese blood feces urine saliva proteins urinary glomerular tubular serums sample matrix matrices same day sameday results | |||
| 500371 | Cortisol Express EIA Kit (Solid Plate) New | - |
|
2010-05-20 | 0E-12 | cortisol-express-eia-kit-solid-plate | Cortisol Express ELISA Kit (Solid Plate) | 10007337 10007176 EIAs steroids antisera hormones enzyme immunoassays reagents antiserums kits ELISAs enzymes glucocorticoids adrenal cortex adrenocorticotropic hormones ACTH circadian stress biomarker major depressive disorders hypertension AIDS cognitive impairment bone density type II 2 diabetes intracellular receptors mineralocorticoid receptors MRs glucocorticoid GRs 11β-hydroxysteroid dehydrogrenase 11β-HSD2 cortisone kidney colon salivary gland hypokalemia 11β-HSD1 visceral adipose tissues obese blood feces urine saliva proteins urinary glomerular tubular serums sample matrix matrices same day sameday results | |||
| 10011296 |
(E)- |
39025-24-6 | ≥98% |
|
2009-12-03 | 0.471069135434 | -e-guggulsterone | anti-flammatory cancers FXR bile acids LDL cholesterol antiinflammatory atherosclerosis obesity diabetes inflammation farnesoid X receptors guggul trees | |||
| 10010019 | FABP2 Polyclonal Antibody | - |
|
2007-10-02 | 16.696056098597 | fabp2-polyclonal-antibody | Intestinal Fatty Acid Binding Protein; Fatty Acid Binding Protein 2; I-FABP | WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting | |||
| 10007938 | FABP2 (rat recombinant) | - | >95% | 2005-12-16 | 22.467799263351 | fabp2-rat-recombinant | Fatty Acid Binding Protein 2; I-FABP; Intestinal-FABP | protein-only fatty acids binding proteins high affinity constants small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology | |||
| 10233 | FABP3 Monoclonal Antibody (Clone CC68) | - | 2009-03-20 | 21.366427255984 | fabp3-monoclonal-antibody-clone-cc68 | Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP | antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting | ||||
| 10007614 | FABP4 (human) EIA Kit | - |
|
2006-10-13 | 21.193254645906 | fabp4-human-eia-kit | Fatty Acid Binding Protein 4 (human) EIA Kit; Adipocyte-FABP (human) EIA Kit; A-FABP (human) ELISA Kit | 10009284 SPI-BIO spibio ELISA immunoassay enzyme A05181 FABP4 fatty acid binding protein adipocytes aP2 atherosclerosis endocrinology assays | |||
| 10010463 | FABP4 (human recombinant) Western Ready Control | - | 2007-10-23 | 10.947190213101 | fabp4-human-recombinant-western-ready-control | Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP | fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting | ||||
| 10009676 | FABP4 (murine recombinant) Western Ready Control | - | 2007-04-30 | 16.605474635861 | fabp4-murine-recombinant-western-ready-control | ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP | fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis | ||||
| 10004944 | FABP4 Polyclonal Antibody | - |
|
2004-11-05 | 21.790949271722 | fabp4-polyclonal-antibody | Fatty Acid Binding Protein 4; aP2; A-FABP; ALBP | atherosclerosis adipocytes macrophages 3T3-L1 fatty acids PPAR.gamma. PPARgamma agonists insulin WB western blots blotting ICC immunocytochemistry hyperinsulinemia deficiency antibodies antiserum antisera endocrinology immunoblotting | |||
| 10010183 | Fatty Acid Amide Hydrolase (human recombinant) | - | 100,000 x g supernatant | 2008-11-05 | 54.928239936858 | fatty-acid-amide-hydrolase-human-recombinant | FAAH (human recombinant) | FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases | |||
| 10005368 | Fenofibrate | 49562-28-9 | >98% |
|
2004-09-15 | 34.996955801105 | fenofibrate | PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology | |||
| 13287 |
FK- |
658084-64-1 | ≥98% |
|
2009-07-21 | 55.106187845304 | fk-866 | K 22.175 | nicotinamides phosphoribosyltransferase NAMPT NamPRT PBEF visfatin mononucleotides adenine dinucleotide NAD+ inhibitors inhibitis inhibition cancers apoptosis SIRT1 autophagy FK866 FK 866 K22.175 K 22175 K22175 NamPRT PBEF visfatin carcinoma cells autophagy | ||
| 13068 | Fucoxanthin | 3351-86-8 | ≥98 |
|
2010-01-29 | 60.796642111725 | fucoxanthin | α-Carotene | carotenoids algae white adipose tissues WAT obesity weight gain uncoupling proteins 1 UCP1 thermogenesis diabetes type 2 hyperinsulinemia glucose insulin all-trans | ||
| 10010622 | Genipin | 6902-77-8 | >98% |
|
2008-05-09 | 150.674033149171 | genipin | (+)-Genipin | obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity | ||
| 10006306 | Ghrelin (human acylated) EIA Kit | - |
|
2004-11-10 | 114.416574585635 | ghrelin-human-acylated-eia-kit | Ghrelin (human acylated) ELISA Kit | spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue A05106 receptors stomach hypothalmic spi-bio spibio A05106 adipokines endocrinology neurochemistry assays ghrelin assay | |||
| 10008952 | Ghrelin (human unacylated) EIA Kit | - |
|
2006-06-30 | 104.471823204419 | ghrelin-human-unacylated-eia-kit | Ghrelin (human unacylated) ELISA Kit | spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05119 adipokines assays ghrelin assay | |||
| 10006307 | Ghrelin (rat acylated) EIA Kit | - |
|
2004-11-10 | 175.312062615101 | ghrelin-rat-acylated-eia-kit | Ghrelin (rat acylated) ELISA Kit | spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05117 adipokines endocrinology neurochemistry assays ghrelin assay | |||
| 10008953 | Ghrelin (rat unacylated) EIA Kit | - |
|
2006-06-30 | 168.283977900552 | ghrelin-rat-unacylated-eia-kit | spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05118 adipokines assays ghrelin assay | ||||
| 10011347 |
Glycerophospho- |
201738-25-2 | ≥97% |
|
✓ | 2009-03-13 | 23.463167587477 | glycerophospho-n-arachidonoyl-ethanolamine | Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE | anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide | |
| 10011357 |
Glycerophospho- |
201738-24-1 | ≥98% |
|
✓ | 2009-02-20 | 26.663259668509 | glycerophospho-n-oleoyl-ethanolamine | cannabinoids neurotransmitter PPARs neurochemistry neuroscience fatty acids amides hydrolase oleoyl ethanolamides methabolism obesity nutrition diet NAPE N-Acyl Phosphatidylethanolamide | ||
| 10136 |
GPR17 (C- |
- |
|
2010-01-19 | 50.866858118477 | gpr17-c-term-polyclonal-antibody | G Protein-Coupled Receptor 17 | proteins receptors antibodies western blots WB ICC signals signaling nucleotides CysLTs amino acids blotting immunoblotting FC flow cytometry immunocytochemistry cysteinyl leukotrienes | |||
| 10007206 | GPR40 Blocking Peptide | - | 2007-04-12 | 2.448784530387 | gpr40-blocking-peptide | immunohistochemistry peptide insulin diabetes breast cancer | |||||
| 10007205 | GPR40 Polyclonal Antibody | - | 2007-04-04 | 9.710902394107 | gpr40-polyclonal-antibody | Free Fatty Acid Receptor; FFAR1; G Protein-Coupled Receptor 40 | immunohistochemistry antibody insulin diabetes breast cancer endocrinology IHC | ||||
| 10011211 | GW 9578 Exclusive | 247923-29-1 | >98% |
|
✓ | 2008-05-23 | 41.644871923656 | gw-9578 | atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated | ||
| 10010324 | Harmine | 442-51-3 | >98% |
|
2007-11-07 | 40.821878453039 | harmine | metabolic syndromes obesity diabetes PPAR.gamma. insulin sensitivity metabolism .beta.-carboline b-carboline alkaloids hyperglycemia signalling pathway inflammatory gene expression endocrinology | |||
| 10010676 |
Hydrochlorothiazide- |
- | ≥99% deuterated product |
|
2009-05-02 | 0E-12 | hydrochlorothiazide-d2-15n2 | 58-93-5 8049-49-8 125727-50-6 edema hypertension diabetes deuterated deuterium | |||
| 589501 | Insulin (rat) EIA Kit | - |
|
199.281197053406 | insulin-rat-eia-kit | Insulin (rat) ELISA Kit | measures kits eias enzyme immunoassays ELISAs diabetes spi-bio spibio A05105 adipokines endocrinology assays | ||||
| 10012699 | JMV3002 Exclusive | 925239-03-8 | ≥98% |
|
✓ | 2009-03-11 | 65.424861878453 | jmv3002 | ghrelins obesity growth hormones foods intake receptors antagonists secretagouge hexarelin-stimulated secretion | ||
| 10011054 | KB2115 Exclusive | 355129-15-6 | ≥98% |
|
✓ | 2008-06-10 | 6.742541436464 | kb2115 | thyroid hormones dyslipidemia LDL cholesterol statins cardiovascular disease atherosclerosis obesity | ||
| 10009280 |
L- |
174627-50-0 | >98% |
|
2007-09-13 | 11.112279005524 | l-759-633 | L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry | |||
| 10009324 | LCAT Blocking Peptide | - | 2007-01-03 | 22.862486187845 | lcat-blocking-peptide | Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol-O-Acyltransferase | antibodies western blotting blots signaling signalling WB controls peptides proteins cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary | ||||
| 10009323 | LCAT Polyclonal Antibody | - |
|
2007-01-03 | 23.646163290361 | lcat-polyclonal-antibody | Lecithin:Cholesterol Acyltransferase; Phosphatidylcholine-Sterol O-Acyltransferase | proteins diseases antibodies antisera antiserum WB western blots blotting cholesterols acetyltransferases phospholipases catalyzes fatty acids transfers sn-2 phosphatidylcholines enzymes esters high-density lipoproteins HDL cells blood-plasma tissues ovary atherosclerosis immunoblotting | |||
| 10007672 | LDL Receptor Blocking Peptide | - | 2007-05-03 | 40.481491712707 | ldl-receptor-blocking-peptide | Low-density Lipoprotein Receptor Blocking peptide; LDLR Blocking Peptide | proteins diseases WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic livers hormonal controls mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 | ||||
| 10007665 | LDL Receptor Polyclonal Antibody | - |
|
2006-02-15 | 55.282596685083 | ldl-receptor-polyclonal-antibody | LDLR Polyclonal Antibody | proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic tails livers hormonal controls in vivo vitro mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 cell-based assay cell based assay cba immunoblotting | |||
| 500010 | Leptin (human) EIA Kit | - |
|
2008-11-17 | 46.864640883977 | leptin-human-eia-kit | Leptin (human) ELISA Kit | 10007607 500600 SPI-BIO SPI Bio kits EIAs ELISAs enzymes immunoassays ob/ob genes obesity measures endocrinology adipokines double-antibody sandwich adipose tissues appetite control fats metabolisms body weights regulations receptors hypothalmus mass index BMI percentages energy secreted circadian fashion nocturnal rise lean patients mutations deficiency mice murine endogenous resistance assays | |||
| 10007609 | Leptin (murine/rat) EIA Kit | - |
|
2006-07-20 | 94.092081031307 | leptin-murine-rat-eia-kit | SPI-BIO spibio ELISA enzyme immunoassay mouse A05176 adipokines endocrinology assays | ||||
| 10007608 | Leptin Receptor (human) EIA Kit | - |
|
2006-07-20 | 74.699815837937 | leptin-receptor-human-eia-kit | SPI-BIO spibio ELISA enzyme immunoassay A05175 adipokines endocrinology assays | ||||
| 500001 | Lipid Droplets Fluorescence Assay Kit | - |
|
2009-05-28 | 33.674033149171 | lipid-droplets-fluorescence-assay-kit | lipids droplets storage organelles cytoplasms eukaryotic cells mammalian adipocytes steroidogenic fatty acids metabolism membranes synthesis phospholipids cholesterols steroids PAT proteins Perilipin adipophilin tail-interacting TIP 47 intracellular homeostasis trafficking signaling immunopathological inflammation anti-inflammatory mediators leukocytes therapy assays kits measures measurements fluorescences fluorescent biogenesis Nile Red microscopy flow cytometry plates readers | ||||
| 600180 |
Melanocortin- |
- |
|
2010-01-05 | 30.470564763658 | melanocortin-3-receptor-step-reporter-assay-kit-luminescence | MC3R | MC-3R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH | |||
| 10006355 |
Melanocortin- |
- |
|
2005-08-03 | 24.438929558011 | melanocortin-4-receptor-polyclonal-antibody | MC4R | antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry melanocortins melanogenesis steroidogenesis sexual functions inflammations appetite regulations energy homeostasis G-proteins coupled receptors GPCRs MC1R MC2R MC3R MC5R transcripts brain genetic studies heteozygous mutations human obesity mammalian unglycosylated SDS-PAGE endocrinology immunoblotting | |||
| 600190 |
Melanocortin- |
- |
|
2010-01-05 | 30.470564763658 | melanocortin-4-receptor-step-reporter-assay-kit-luminescence | MC4R | MC-4R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands sexual function antagonists fever suppression inflammatory mediators in vivo Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH | |||
| 10007812 | Monoacylglycerol Lipase (human recombinant) | - | >95% |
|
2008-04-01 | 110.429965469613 | monoacylglycerol-lipase-human-recombinant | MAGL; MGL | neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant | ||
| 10004184 | NESS 0327 Exclusive | 494844-07-4 | >98% |
|
✓ | 2008-05-27 | 35.890121546960 | ness-0327 | neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity | ||
| 10009661 |
N- |
- | >95% |
|
2008-04-23 | 0E-12 | n-octadecyl-n-propyl-sulfamide | PPAR.alpha. PPARa PPARalpha OEA satiety obesity metabolism food intake triglyceride lipids activators appetite suppression | |||
| 10010547 |
O- |
439146-24-4 | >98% |
|
✓ | 2008-03-31 | 43.893867403314 | o-arachidonoyl-glycidol | 2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL | ||
| 90265 | Oleoyl Ethanolamide | 111-58-0 | >98% |
|
42.939094853549 | oleoyl-ethanolamide | Oleic Acid Ethanolamide; OEA | cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides | |||
| 10007823 |
Oleoyl Ethanolamide- |
- | ≥99% deuterated product |
|
2006-03-06 | 69.649184182236 | oleoyl-ethanolamide-d2 | OEA-d2; Oleic Acid Ethanolamide-d2 | GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides | ||
| 9000552 |
Oleoyl Ethanolamide- |
- | ≥99% deuterated product |
|
✓ | 2010-01-12 | 100.628998218902 | oleoyl-ethanolamide-d4 | Oleic Acid Ethanolamide-d4; OEA-hydroxyethyl-1,1,2,2-d4 | cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience | |
| 600240 | Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) New | - |
|
2010-03-31 | 0E-12 | orexin-1-receptor-step-reporter-assay-kit-luminescence | OX1R | hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists | |||
| 600250 | Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) New | - |
|
2010-03-31 | 0E-12 | orexin-2-receptor-step-reporter-assay-kit-luminescence | OX2R | hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists | |||
| 10005426 | Orlistat New | 96829-58-2 | 98% |
|
2010-03-30 | 40.935386740331 | orlistat | Xenical; Tetrahydrolipstatin; Alli | DAGL 2-AG obesity gastric pancreatic lipases carboxyl esters inhibitors GIP 111397-16-1 GLP-1 anti-obesity antiobesity CCK PP inhibition inhibited GLP 1 GLP1 diacylglycerol | ||
| 10010374 |
p38 MAPK (Phospho- |
- |
|
2007-09-17 | 3.287292817679 | p38-mapk-phospho-thr180-tyr182-cell-based-phosphorylation-translocation-assay-kit | phosphorylation kits assays enzymes diseases asthma autoimmunity stress response nervous system fluorescence fluorescent fluorometric | ||||
| 10218 | PCSK9 Monoclonal Antibody (Clone 15A6) | - |
|
2008-10-29 | 20.020184162063 | pcsk9-monoclonal-antibody-clone-15a6 | Proprotein Convertase Subtilisin Kexin 9; NARC-1 | antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots | |||
| 10240 | PCSK9 Polyclonal Antibody | - |
|
2009-07-21 | 7.141795580110 | pcsk9-polyclonal-antibody | NARC-1; Proprotein Convertase Subtilisin Kexin 9 | PCSK-9 PCSK 9 western blots ICC WB immunocytochemistry protease LDLs lipoproteins low-density low density cholesterol immunoblotting blotting | |||
| 301707 |
PGC- |
- | 2006-07-25 | 13.382928176796 | pgc-1-blocking-peptide | antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases proteins peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity | |||||
| 101707 |
PGC- |
- |
|
2005-10-12 | 33.914053239578 | pgc-1-polyclonal-antibody | PPARγ Coactivator 1; Peroxisome Proliferator-activated Receptor γ Coactivator 1 | atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity endocrinology immunoblotting | |||
| 10008654 | Pinolenic Acid Exclusive | 16833-54-8 | >98% |
|
✓ | 2006-09-07 | 15.491823204419 | pinolenic-acid | fatty acids polyunsaturated PUFAs CCK GLP-1 ApoA-I ApoA-1 ApoA1 Korean pine maritime seed oils HDL high-density lipoproteins DELTA5 .DELTA.5 D5 phosphatidylinositol fraction HepG2 cells | ||
| 10008658 | Pinolenic Acid ethyl ester | 493015-74-0 | >98% |
|
2006-09-15 | 1.450856353590 | pinolenic-acid-ethyl-ester | fatty acids polyunsaturated PUFAs CCK GLP-1 ApoAI ApoA-I ApoA1 ApoA-1 Korean pine maritime seed oils HDL high-density lipoproteins DELTA5 .DELTA.5 D5 phosphatidylinositol fraction HepG2 cells lipophilic | |||
| 10008656 | Pinolenic Acid methyl ester | 38406-57-4 | >98% |
|
2007-01-16 | 2.417707182320 | pinolenic-acid-methyl-ester | fatty acids polyunsaturated PUFAs CCK GLP-1 ApoAI ApoA-I ApoA1 ApoA-1 Korean pine maritime seed oils HDL high-density lipoproteins DELTA5 .DELTA.5 D5 phosphatidylinositol fraction HepG2 cells lipophilic esters | |||
| 10009088 | PPARα LBD (human recombinant) | - | >90% | 2006-09-13 | 12.125559392264 | ppar-lbd-human-recombinant | Peroxisome Proliferator-activated Receptor α Ligand Binding Domain | receptors PPAR.alpha.1 PPAR.alpha.2 PPARa1 PPARa2 Proteins Ligands domains PPAR's Ligand-activated transcription factors atherosclerosis endocrinology PPARalpha | |||
| 10006915 | PPARα Transcription Factor Assay Kit | - |
|
2005-08-25 | 69.979846093133 | ppar-transcription-factor-assay-kit | Peroxisome Proliferator-activated Receptor α Transcription Factor Assay Kit | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF | |||
| 10008878 | PPARα, δ, γ Complete Transcription Factor Assay Kit | - |
|
2006-08-22 | 51.581933701657 | ppar-complete-transcription-factor-assay-kit | PPARα PPARδ PPARγ PPAR-α PPAR-δ PPAR-γ PPAR α PPAR δ PPAR γ PPARalpha PPARdelta PPARgamma PPAR-alpha PPAR-delta PPAR-gamma delta alpha gamma PPAR.alpha. PPAR.delta. PPAR.gamma. PPAR-.alpha. PPAR-.delta. PPAR-.gamma. .alpha. .gamma. .delta.peroxisomes proliferator-activated proliferator activated receptors PPARs completes TF factors assay kits atherosclerosis endocrinology metaboli syndrome metabolism nuclear obese obesity PPAR non-radioacitve radioactive DNA detecting whole cells lysates 96-wells 96 wells immunosorbent ELISA enzyme-links enzyme-linked enzyme links linked electrophoretic mobility shifts EMSA double stranded dsDNA HRP colorimetric | ||||
| 10009987 | PPARγ FL (human recombinant from Sf21 cells) | - | >80% by SDS-PAGE | 2007-06-15 | 17.833683241252 | ppar-fl-human-recombinant-from-sf21-cells | Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) | proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology | |||
| 10007941 | PPARγ LBD (human recombinant) | - | >90% | 2006-03-16 | 24.550812943962 | ppar-lbd-human-recombinant | Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent | |||
| 10006855 | PPARγ Transcription Factor Assay Kit | - |
|
2005-08-25 | 83.255528111797 | ppar-transcription-factor-assay-kit | Peroxisome Proliferator-activated Receptor γ Transcription Factor Assay Kit | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF | |||
| 10006247 | PPARδ Blocking Peptide | - | >70% | 2004-11-09 | 4.264530386740 | ppar-blocking-peptide | PPARβ; Peroxisome Proliferator-activated Receptor δ; NR1C2 | controls peptides western blots WB immunoblotting antibodies receptors PPARbeta PPAR.beta. lipid metabolism obesity special:month specialdiscount:15 specialstart:2008-02-01 specialend:2008-02-29 | |||
| 10007451 | PPARδ (human recombinant) | - | >95% | 2005-07-29 | 9.948187845304 | ppar-human-recombinant | PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1; FAAR | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 | |||
| 101720 | PPARδ Polyclonal Antibody | - |
|
2004-11-05 | 15.819088397790 | ppar-polyclonal-antibody | Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ | PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting | |||
| 10006914 | PPARδ Transcription Factor Assay Kit | - |
|
2005-08-23 | 49.096223362273 | ppar-transcription-factor-assay-kit | Peroxisome Proliferator-activated Receptor δ Transcription Factor Assay Kit | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF | |||
| 10009568 | PPARδ Western Ready Control | - | 2007-02-02 | 7.238066298342 | ppar-western-ready-control | Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1 | peroxisome proliferative-activated receptor PPARd xenopus laevis PPARb PPAR.beta. liver intesine kidney abdominal adipose skeletal muscle lipids metabolism cholesterol homeostasis embryos cancers obesity atherosclerosis endocrinology | ||||
| 13365 |
Programmed Cell Death Protein 4 (C- |
- | 2008-08-25 | 0E-12 | programmed-cell-death-protein-4-c-term-blocking-peptide | PDCD4 | antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots PDCD4 PCDC-4 PDCDP4 PDCDP-4 | ||||
| 10008593 | PSN375963 | 388575-52-8 | >98% |
|
2006-08-01 | 30.706698895027 | psn375963 | GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology | |||
| 10008594 | PSN632408 | 857652-30-3 | >98% |
|
2006-08-01 | 40.699189686925 | psn632408 | GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry | |||
| 13346 | Rapamycin | 53123-88-9 | ≥98% |
|
2009-10-21 | 38.575802540001 | rapamycin | Sirolimus | immunosuppresssants transplants rejection inhibitors IL-2 lymphocytes B cells T FKBP12 mTOR mTORC1 cancer adipogenesis diabetes tuberous sclerosis cardiovascular diseases | ||
| 10007610 | Resistin (human) EIA Kit | - |
|
2006-07-20 | 12.350828729281 | resistin-human-eia-kit | FIZZ3; ADSF | SPI-BIO spibio ELISA immunoassay enzyme A05177 adipokines endocrinology assays | |||
| 10007612 | Resistin (rat) EIA Kit | - |
|
2006-10-13 | 29.959668508287 | resistin-rat-eia-kit | FIZZ3; ADSF | SPI-BIO spibio ELISA immunoassay enzyme A05179 endocrinology assays | |||
| 9000484 | Rimonabant | 168273-06-1 | ≥98% |
|
2009-06-17 | 35.504088397789 | rimonabant | SR141716 | SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory | ||
| 10006415 |
Ro 48- |
161582-11-2 | >98% |
|
2005-06-01 | 30.147645027624 | ro-48-8071 | monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis | |||
| 10007682 | Serum Retinol Binding Protein 4 Blocking Peptide | - | 2007-07-30 | 0E-12 | serum-retinol-binding-protein-4-blocking-peptide | pRBP Blocking Peptide; Plasma Retinol Binding Protein 4 Blocking Peptide; sRBP4 Blocking Peptide | wb western blotting TTR serum type 2 diabetes sRBP plasma SRBP-4 blots proteins serums retinols insulin special:month specialdiscount:15 specialstart:2007-08-01 specialend:2007-09-30 RBP | ||||
| 10007818 | Serum Retinol Binding Protein 4 (human recombinant) | - | >95% | 2006-10-05 | 23.712120165746 | serum-retinol-binding-protein-4-human-recombinant | RBP4; sRBP4 | proteins vitamin A blood mammals .beta.-sheet-rich lipocalins hepatocytes plasma tetrameric transthyretin TTR adipocyte-derived adipocytes signaling type 2 diabetes insulin C-terminal terminus hexahistidine tag endocrinology | |||
| 10007681 | Serum Retinol Binding Protein 4 Polyclonal Antibody Exclusive | - |
|
✓ | 2007-08-03 | 4.897116022099 | serum-retinol-binding-protein-4-polyclonal-antibody | Plasma Retinol Binding Protein 4; pRBP; sRBP4 | vitamin A wb western blotting type 2 diabetes lipocalin TTR transthyretin sRBP4 sRBP-4 proteins adipocytes signals signalling signaling insulin blots retinols serums RBP atherosclerosis endocrinology immunoblotting | ||
| 10009754 | Serum Retinol Binding Protein Western Ready Control Exclusive | - | ✓ | 2008-07-08 | 0.441988950276 | serum-retinol-binding-protein-western-ready-control | sRBP4; RBP4 | proteins C-terminal western blots immunoblotting WB SRBPs hexahistidine His-tag His-tagged insulin resistance tyep 2 diabetes pathogenesis blotting | |||
| 10009239 |
SREBP- |
- |
|
2007-04-17 | 27.773281767955 | srebp-2-cell-based-translocation-assay-kit | Sterol Regulatory Element-Binding Protein-2 Cell-Based Translocation Assay Kit | sterol regulatory element binding proteins athersclerosis cholesterols fatty acids triglycerides phospholipids helix-loop-helix HLH transcription factors DyLight Pierce Biotechnology assays fluorescence fluorescent fluorometric cell-based assays cell based assay cba | |||
| 10007663 |
SREBP- |
- |
|
2006-02-22 | 77.802662983425 | srebp-2-polyclonal-antibody | Sterol Regulatory Element-binding Transcription Factor 2; SREBF2; Sterol Regulatory Element-binding Protein-2 | atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry 1a 1c basic helix-loop-helix bHLH transcription factors lipids homeostasis regulating genes cholesterols fatty acids metabolisms domains amino-terminals hydrophobic regions transmembranes segments carboxy regluates synthesis genes HMG-CoA reductases enzymes synthetics pathways tissues basal ER endoplasmic reticulum membranes glycosylateds proteins nucleus cells livers brown fats testis HepG2 human fibroblasts endocrinology immunoblotting | |||
| 10007819 |
SREBP- |
- |
|
2006-09-20 | 26.722014449638 | srebp-2-transcription-factor-assay-kit | Sterol Regulatory Element-binding Protein-2 Assay Kit | tf sterol regulatory element binding proteins cholesterol fatty acids triglycerides phospholipids atherosclerosis assays | |||
| 10009749 |
SREBP- |
- | 94 kDa (GST-tagged); 68 kDa (native) | 2007-07-30 | 17.977790055248 | srebp-2-western-ready-control | Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein 2; SREBPF2 | WB western blot helix loop bHLH fatty acids genes cholesterol regulatory HMG-CoA tissues E. coli SREBP2 SREBPF-2 transcription factors SREBP 2 atherosclerosis | |||
| 10009022 |
(S)- |
464213-10-3 | >98% |
|
✓ | 2007-08-16 | 3.310856353590 | -s-slv-319 | CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands | ||
| 10005263 | TOFA | 54857-86-2 | >98% |
|
2004-07-28 | 20.117458563536 | tofa | RMI 14514; 5-(Tetradecyloxy)-2-Furoic Acid | inhibits inhibitors inhibition ACC acetyl-CoA carboxylases fatty acid synthases synthesis FAS cerulenin apoptosis cancer C75 malonyl-CoA atherosclerosis endocrinology | ||
| 13261 | URB447 Exclusive | 1132922-57-6 | ≥98% |
|
✓ | 2009-06-18 | 29.640718232043 | urb447 | CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 | ||
| 700320 | Uric Acid Assay Kit New | - |
|
2010-08-30 | 0E-12 | uric-acid-assay-kit | Urate Assay Kit | kits assays measures measurement acids human purines metabolisms urine serum renal excretion excreted allantoin enzymes urate oxidases uricase genes obesity alcohol consumption hyperuricemia gout kidney stones metabolic syndromes hypertension cardiovascular diseases exercise-induced acute failure hypouricemia | |||
| 70730 | Wy 14643 | 50892-23-4 | >98% |
|
123.218149171270 | wy-14643 | Pirinixic Acid | activators peroxisome proliferator-activated receptors adipocytes obesity PPARalpha PPAR. nuclear receptors alpha. PPARgamma PPAR.gamma. PPARdelta PPAR.delta. atherosclerosis endocrinology wy14643 | |||
| 71800 |
(Z)- |
39025-23-5 | ≥98% |
|
2009-12-01 | 1.714984453480 | -z-guggulsterone | anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2010 Cayman Chemical Company
Quick Search